Skip to main content

Find Clinical Trials

Home
Conditions
Rabies

Clinical trial condition

Rabies

Explore clinical trials studying Rabies. Study availability and eligibility vary by location and protocol.

80 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Rabies trial results

Completed

Non-specific Effects of Rabies Vaccine

NCT03656198

Conditions: Body Temperature Changes, Diarrhea, Fever, +13 more
Locations: Ross University School of Veterinary Medicine Basseterre, Saint Kitts and Nevis

View Trial Details

Completed

Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.

NCT02564471

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: State University of New York, Upstate Medical University (SUNY-UMU) Syracuse, New York, United States

View Trial Details

Completed

Immunity Duration of Rabies Vaccine and Booster Dose Effects at 10 Years Post-primary Vaccination

NCT03774628

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Lianshui Xinyi Center for Disease Control and Prevention Huai'an, Jiangsu, China

View Trial Details

Completed

Simplifying the Rabies Pre-exposure Vaccination

NCT01388985

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Military Hospital Brussels, Belgium

View Trial Details

Completed

RNActive® Rabies Vaccine (CV7201) in Healthy Adults

NCT02241135

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Abteilung für Infektions- und Tropenmedizin der Ludwig-Maximilians-Universität Munich, Germany

View Trial Details

Completed

Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults

NCT02238756

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: CRS Clinical Research Services Mönchengladbach GmbH Mönchengladbach, Germany

View Trial Details

Completed

Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response

NCT01610362

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Queen Saovabha Memorial Institute, Thai Red Cross Society Bangkok, Thailand

View Trial Details

Completed

Immunogenicity and Safety Study of A New Chromatographically Purified Vero Cell Rabies Vaccine With ID Regimen and ERIG

NCT01137045

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Suda Sibunruang Bangkok, Thailand

Queen Saovabha Memorial Institute Bangkok, Thailand

View Trial Details

Completed

Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins

NCT01641315

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Queen Saovabha Memorial Institute Bangkok, Thailand

View Trial Details

Completed

Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure Use

NCT01784874

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Redding, California, United States

Sacramento, California, United States

Omaha, Nebraska, United States

Austin, Texas, United States

View Trial Details